North America to Dominate the Long Read Sequencing Market

Introduction

The DNA sequencing technology has become indispensable in biological research, and numerous applied fields, such as medical diagnosis, biotechnology, forensic biology, virology, and medical genetics. The comparison of healthy and mutated DNA sequences aids in diagnosing various diseases, including cancer. Determining a simple method of DNA sequencing enables the implementation of faster and individualized medical treatment. The apparent long-read sequencing provides longer reads to overcome various computational difficulties surrounding the assembly of genomes, transcript reconstruction, and metagenomics, compared to current generation sequencing technologies.

Long read sequencing offers many advantages over short read or second-generation sequencing techniques, further driving the market growth. For instance, long reads generated by single-molecule real-time sequencing (SMRT) provides a comprehensive overview of the entire genome and is used to distinguish genetic and structural variants. In 2015, researchers estimated that long-read sequencing can be used to assemble umpteen bacterial and viral genomes. Apart from this, rising awareness about long read sequencing and increasing investments in R&D activities provide an impetus to the market growth.

Key Highlights

• The long read sequencing market size was estimated at USD 973.6 million in 2019 and is expected to grow with a CAGR of 24% on account of increasing R&D investment by governments and market players on long read sequencing technologies.
• The single-molecule real-time (SMRT) sequencing segment holds the highest market share as it helps in achieving high accuracy due to low systematic bias and longer read lengths.
• The consumables segment held the largest market share in 2018 owing to the regular procurement of consumable items by the end-users.
• North America leads the long read sequencing market on account of the strong presence of leading market players such as Pacific Biosciences and reputable informatics network.

Competitive Players

Key Players

• Pacific Biosciences of California, Inc.
• Oxford Nanopore Technologies Limited
• Future Genomics Technologies B.V.
• Garvan Institute of Medical Research
• Quantapore, Inc.
• Stratos Genomics, Inc.
• Institute of Integrative Biology of the Cell (I2BC)
• Genome Transcriptome Facility of Bordeaux
• Takara Bio, Inc.
• MicrobesNG
• BaseClear B.V.
• NextOmics

Recent Developments

Recent Development

• In March 2019, Oxford Nanopore introduced Flongle for rapid and long DNA / RNA sequence analysis to expand its product portfolio. Small Flongle cells can produce about 1.8 Gb of long read sequence data with headroom for more than 3 Gb.

Segmentation

Long Read Sequencing Market Segmentation

By Technology

• Single-molecule real-time sequencing (SMRT)
• Nanopore sequencing

By Product

• Instruments
• Consumables
• Services

By Application

• Identification and fine mapping of structural variation
• Tandem repeat sequencing
• Resolving allele phasing
• Reproductive genomics
• Cancer
• Viral and microbial sequencing

By Region

• North America
• Europe
• Asia-Pacific
• South America
• The Middle East and Africa